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Cyclin A/CDK2 Regulates V(D)J Recombination
by Coordinating RAG-2 Accumulation and DNA Repair
Homologous recombination, in addition to Mre11,
Rad50, and Xrs2, involves the proteins RPA (Umezu et
al., 1998), Rad51, Rad52, Rad54, Rad55, and Rad57
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The Johns Hopkins University School of Medicine (Sugawara et al., 1995) as well as the replicative DNA
polymerases (Holmes and Haber, 1999). In buddingBaltimore, Maryland 21205
yeast, homologous recombination is dependent on
Rad52 but does not require Ku (Holmes and Haber,
1999). Human Rad52 binds DNA ends, protects themSummary
from exonuclease III, and promotes end-to-end DNA
joining (Van Dyck et al., 1999). Rad52 and Ku may com-Accumulation of the V(D)J recombinase protein RAG-2
pete for DNA ends, channeling DSBs into alternativeis restricted to G0/G1 cells by phosphorylation-medi-
repair pathways (Van Dyck et al., 1999). In mammalianated degradation at the G1-S boundary. Here cyclin
cells, the NHEJ pathway appears to predominate duringA/CDK2 is shown to oppose RAG-2 accumulation;
the G1 and early S phases (Maser et al., 1997; Takata etconversely, RAG-2 is induced by p27Kip1 and related
al., 1998), while recombinational repair is preferentiallyCDK inhibitors. Coinduction of RAG-2 and G1 delay by
used in late S and G2 (Takata et al., 1998).p27Kip1 is accompanied by strong stimulation of V(D)J
V(D)J recombination is coupled to the cell cycle byrecombination. Unexpectedly, induction of RAG-2 ac-
periodic destruction of RAG-2 protein (Lin and Desi-cumulation in the absence of G1 delay has no effect on
recombination frequency. p27Kip1 may stimulate V(D)J derio, 1993, 1994; Li et al., 1996). RAG-2 accumulates
recombination by coordinating accumulation of RAG-2 preferentially in G0/G1 cells and is degraded at the G1-S
with prolongation of G1, when nonhomologous end transition in dividing cells (Lin and Desiderio, 1994). De-
joining is preferentially active. Consistent with this, struction of RAG-2 is triggered by phosphorylation at
enforced expression of RAG-2 throughout cell cycle Thr-490, which lies within a consensus substrate se-
is associated with accumulation of aberrant recombi- quence for CDK2, CDC2, and CDK4 (Lin and Desiderio,
nation products reminiscent of those formed in the 1993; Li et al., 1996). Several CDK complexes can phos-
absence of nonhomologous end joining. phorylate this site in vitro, including cyclin E/CDK2 and
cyclin A/CDK2 (Li et al., 1996), but the kinase(s) responsi-
ble for phosphorylation in vivo has remained undefined.
V(D)J recombination signal end intermediates also ac-Introduction
cumulate preferentially or exclusively in G0/G1 phase
cells (Schlissel et al., 1993; Desiderio et al., 1996), andV(D)J recombination, the process by which antigen re-
this periodicity is linked to cell cycle±dependent accu-ceptor genes are assembled (Lewis, 1994), is initiated by
mulation of RAG-2: in transgenic mice expressing a con-the recombination activating proteins RAG-1 and RAG-2
stitutive Thr-490→Ala RAG-2 mutant, signal ends accu-(Schatz et al., 1989; Oettinger et al., 1990). These pro-
mulate at similar levels in G0/G1 and G2/M phaseteins cleave DNA at the junctions between coding seg-
thymocytes (Li et al., 1996). The physiologic significancements and recombination signal sequences (RSSs) to
of this coupling has been poorly understood, althoughproduce signal ends, which terminate in blunt double-
the phylogenetic invariance of the RAG-2 cell cycle regu-strand breaks (DSBs), and coding ends, which terminate
latory region (Li et al., 1996) suggests a critical function.in hairpins (McBlane et al., 1995; van Gent et al., 1995;
As one approach to this question, we sought to identifyvan Gent et al., 1996). The subsequent formation of
the specific cyclin/CDK complex(es) that regulate RAG-2coding and signal joints requires several proteins that
accumulation, reasoning that this complex might inte-function in general double-strand DNA break repair
grate pathways by which internal and extracellular cues(DSBR).
modulate V(D)J recombination. G1/S cyclin/CDK com-There are two general mechanisms for DSBR in eukary-
plexes seemed likely candidates for this function be-otic cells: nonhomologous end joining (NHEJ) or ho-
cause RAG-2 undergoes rapid degradation upon enter-mologous recombination. NHEJ involves at least seven
ing S phase.proteins: Ku70, Ku80, DNA ligase IV, XRCC4, Mre11,
CDK2, CDK4, and CDK6 are expressed preferentiallyRad50, and Xrs2 in yeast or Nbs1 in mammalian cells
in the G1 and S phases. All are active at the G1/S bound-(Carney et al., 1998; Critchlow and Jackson, 1998; Varon
ary (for review see Sherr, 1996) but differ with respectet al., 1998). The Ku proteins, DNA ligase IV, and XRCC4
to cyclin association, cell cycle±dependence of activity,are essential for V(D)J recombination (reviewed in Gra-
and substrate specificity. CDK4 and CDK6 associatewunder et al., 1998). Although an Mre11/RAD50 complex
preferentially with type D cyclins, while CDK2 associatespossesses a 39-59 exonuclease activity (Paull and Gel-
preferentially with cyclins A, E, and B (Sherr, 1996). Inlert, 1998) and an Nbs1-dependent, ATP-stimulable hair-
cells entering cycle, cyclin D±associated CDK activitiespin cleavage activity (Paull and Gellert, 1999), participa-
first appear in mid-G1 and persist with relatively littletion of Mre11, Rad50, or Nbs1 in V(D)J recombination
variation in dividing cells (Matsushime et al., 1992; Mey-has not been demonstrated.
erson and Harlow, 1994). Cyclin E/CDK2 activity is tran-
siently expressed in late G1 and early in S phase, while* To whom correspondence should be addressed (e-mail: sdesider@
jhmi.edu). cyclin A/CDK2 activity increases sharply at the G1/S
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boundary and is maintained until M phase entry (Pines
and Hunter, 1990; Dulic et al., 1992; Koff et al., 1992;
Rosenblatt et al., 1992). In comparison to cyclin D1/
CDK4, cyclin A/CDK2 and cyclin E/CDK2 have 10- to
100-fold greater kinase activity toward the consensus
site S/T-P-X-K/R (Kitagawa et al., 1996), which conforms
to the sequence at Thr-490 of RAG-2 (T-P-K-R).
In this communication we examine the regulation of
RAG-2 expression by cyclin/CDK complexes and un-
cover a novel relationship between p27Kip1 activity and
the frequency of V(D)J recombination. We show that
accumulation of RAG-2 is opposed specifically by the
activity of cyclinA/CDK2. Correspondingly, RAG-2 is in-
duced by the CDK inhibitors p21Cip1, p27Kip1, and p57Kip2.
Coinduction of RAG-2 and G1 delay by p27Kip1 is accom-
panied by a 10- to 40-fold stimulation of V(D)J recombi-
nation. Surprisingly, induction of RAG-2 accumulation
in the absence of G1 delay has no effect on V(D)J recom-
bination frequency. This suggested that p27Kip1 CDK inhi-
bition stimulates V(D)J recombination by coordinating
accumulation of RAG-2 with prolongation of G1, when
NHEJ is preferentially active. Consistent with this, en-
forced expression of RAG-2 throughout the cell cycle
is associated with accumulation of aberrant recombina-
tion products reminiscent of those formed in the ab-
sence of nonhomologous end joining. The temporal co-
incidence of RAG-2 accumulation and NHEJ activity in
normal cells could serve to coordinate RAG-mediated Figure 1. CDK2 Regulates Accumulation of RAG-2
DNA cleavage with the completion of V(D)J recombina- (A) Dominant negative CDK2 specifically induces RAG-2 accumula-
tion. Induction of RAG-2 accumulation by wt and dn CDK2 (uppertion by NHEJ. Moreover, these results suggest that
panel); wt and dn CDK3 (middle panel); and wt and dn CDC2 (lowerphysiologic extracellular stimuli, such as cytostatic cy-
panel). Hemagglutinin (HA)-tagged wt or dn CDKs were coexpressedtokines, or environmental insults, such as ionizing radia-
with RAG-2 in 293 cells by transient transfection. Increasing
tion, may affect the frequency of V(D)J recombination by amounts of CDK-expressing plasmid were transfected as indicated;
induction of cyclin-dependent kinase inhibitors (CKIs), the amount of pcRAG-2 was held constant at 10 mg. DNA was
suppression of cyclin A/CDK2, prolongation of G1, and equalized by addition of pcDNA1. Lysates were prepared 48 hr after
transfection; RAG-2 and CDKs were detected by immunoblottingaccumulation of RAG-2.
with antibodies to RAG-2 or HA, respectively. Lane 1, pcDNA1 vector
alone; lanes 2 and 7, RAG-2 alone; lanes 3 and 8, RAG-2 and 1 mg
Results and Discussion of CDK-HA; lanes 4 and 9, RAG-2 and 2.5 mg of CDK-HA; lanes 5
and 10, RAG-2 and 5 mg of CDK-HA; lanes 6 and 11, RAG-2 and 10
Accumulation of RAG-2 Is Opposed by CDK2 mg of CDK-HA.
(B) Wild-type CDK2 specifically reverses RAG-2 accumulation in-and Cyclin A
duced by dn CDK2. Wild-type and dn CDKs were examined forTo define CDKs that govern RAG-2 accumulation in vivo,
the ability to reverse the inhibitory effects of dn CDKs on RAG-2we examined the ability of candidate dominant negative
degradation. Equal amounts of pcRAG-2 (10 mg) were transfected
(dn) CDK mutants, relative to their wild-type (wt) CDK into 293 cells (lanes 2±11). RAG-2 and CDKs were assayed at 48 hr
counterparts, to induce hyperaccumulation of RAG-2 after transfection by immunoblotting as above. Lane 1, pcDNA 1
protein. CDK2, CDK3, and CDC2 were selected for anal- vector alone; lane 2, RAG-2 alone; lane 3, RAG-2 and dn CDK2 (5
mg); lane 4, RAG-2, dn CDK2 (5 mg), and wt CDK2 (5 mg); lane 5,ysis based on their activity profiles and the timing of
RAG-2 and dn CDK2 (10 mg); lane 6, RAG-2 and dn CDK3 (5 mg);RAG-2 accumulation in the cell cycle. CDK activity is
lane 7, RAG-2, dn CDK3 (5 mg), and wt CDK3 (5 mg); lane 8, RAG-2abolished by mutation of a conserved aspartate residue
and dn CDK3 (10 mg); lane 9, RAG-2 and dn CDC2 (5 mg); lane 10,
(D145 in CDK2) in the ATP binding site; these mutants RAG-2, dn CDC2 (5 mg), and wt CDC2 (5 mg); lane 11, RAG-2 and
inhibit the activity of endogenous CDKs when overex- dn CDC2 (10 mg). Amounts of transfected DNA were equalized by
pressed (van den Heuvel and Harlow, 1993). Dominant addition of pcDNA1 vector.
negative CDK2 and CDK3 mutants arrest cells in G1;
these phenotypes can be rescued by the corresponding
wt kinases (van den Heuvel and Harlow, 1993). wt CDK in inducing RAG-2 hyperaccumulation, and (2)
the hyperaccumulation phenotype associated with aIncreasing amounts of hemagglutinin-tagged wt CDKs
or dn CDK mutants were coexpressed with RAG-2 in particular dn mutant CDK could be rescued by coex-
pression of the corresponding wt kinase. Among the293 cells by transient transfection (see Experimental
Procedures). Accumulation of RAG-2 protein and ex- three CDKs tested, only mutant and wt CDK2 showed
a differential effect on RAG-2 accumulation (Figure 1A).pression of individual CDKs were monitored by immu-
noblotting, and the effects of dn and wt CDKs on RAG-2 Induction of RAG-2 hyperaccumulation by dn CDK2 was
rescued by coexpression of wt CDK2 but not by in-accumulation were compared. An effect was considered
specific if (1) the dn mutant was more effective than the creased transfection of the dn mutant (Figure 1B, lanes
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and 5). In contrast to cyclin A, overexpression of cyclin
E had little or no effect on the induction of RAG-2 by
dn CDK (Figure 2B, lanes 5 and 6). Cyclin E did, however,
reverse the modest increase in RAG-2 protein induced
by wt CDK2 (Figure 2B, lanes 3 and 4). This effect was
consistent with the results obtained for cyclin A, as
cyclin E/CDK2 induces cyclin A expression through the
E2F pathway (Schulze et al., 1995; Zerfass-Thome et al.,
1997). This interpretation is reinforced by the inability
of cyclin E to reverse RAG-2 hyperaccumulation in the
presence of dn CDK2. Overexpression of cyclin D1 did
not relieve RAG-2 hyperaccumulation induced by CDK2
(Figure 2C, lanes 3±6). In fact, RAG-2 accumulated to a
higher level when transfected with cyclin D1 and wt
CDK2 than when transfected with CDK2 alone (Figure
2C, lanes 3 and 4), consistent with the ability of cyclin
D1 to form inactive complexes with CDK2 (Ewen et al.,
1993; Higashi et al., 1996). Taken together, these re-
sults indicate that cyclin A/CDK2 opposes accumulation
of RAG-2, and suggest that cyclin E/CDK2 or cyclin
D±containing complexes cannot substitute directly for
cyclin A/CDK2 in this function. This is consistent with
the specific accumulation of RAG-2 at the G0 and G1
cell cycle phases (Lin and Desiderio, 1994; Li et al.,
1996), when cyclin A/CDK2 activity is absent (Resnitzky
et al., 1995). Notably, the results may also explain the
inverse correlation between cyclin A expression and
RAG-2 accumulation in immature thymocytes (Hoffman
Figure 2. Cyclin A Specifically Opposes Accumulation of RAG-2 et al., 1996).
Protein in Concert with CDK2
Cyclins A (A), E (B), or D1 (C) were expressed with RAG-2 and HA- Cyclin-Dependent Kinase Inhibitors of the p21Cip1
tagged CDKs by cotransfection into 293 cells as indicated. Equal Group Induce Accumulation of RAG-2
amounts of RAG-2 expression plasmid were transfected in lanes
Cyclin A/CDK2 and cyclin E/CDK2 complexes are bound2±6 of each panel. RAG-2 and CDKs were detected by immunoblot-
and inactivated by the p21Cip1 family of CKIs (see Sherrting as in Figure 1. Lane 1, vector alone; lane 2, RAG-2; lane 3,
RAG-2 and wt CDK2; lane 4, RAG-2, wt CDK2, and cyclin; lane 5, and Roberts, 1995, for review). Inhibitory cytokines such
RAG-2 and dn CDK2; lane 6, RAG-2, dn CDK2, and cyclin. Cyclins as TGFb (Reynisdottir et al., 1995) and DNA damage (Di
are identified at left. Leonardo et al., 1994; el-Deiry et al., 1994) elevate CKI
activity and suppress cell cycle progression. Because
cyclin A/CDK2 opposes RAG-2 accumulation, p21Cip1
3±5). In contrast, induction of RAG-2 hyperaccumulation and related CKIs would be expected to increase accu-
by dn CDK3 or CDC2 was either unrelieved (Figure 1B, mulation of RAG-2 protein. To test this, the related pro-
lanes 6±8) or increased (Figure 1B, lanes 9±11) by over- teins p21Cip1, p27Kip1, or p57Kip2 were individually overex-
expression of wt CDK3 or CDC2. Using a pulse-chase pressed with RAG-2 by cotransfection into 293 cells. All
protocol described previously (Li et al., 1996), coexpres- three CKIs induced hyperaccumulation of RAG-2 in a
sion of dn CDK2 was observed to increase the half-life dose-responsive fashion (Figures 3A±3C). The yield of
of RAG-2 protein to the same level observed for the RAG-2 protein was strikingly sensitive to p27Kip1, reach-
RAG-2 Thr-490→Ala mutant (Figure 3D). In combination ing a plateau upon a small increase in the level of p27Kip1
with previous results indicating that the half-life of (Figure 3B). Cotransfection of p27Kip1 increased the half-
RAG-2 protein is regulated by phosphorylation (Lin and life of RAG-2 20-fold, from about 14 min to greater than
Desiderio, 1993), these observations provide strong evi- 280 min, an effect similar to that observed upon coex-
dence that CDK2 is a specific inducer of RAG-2 degrada- pression of dn CDK2 or mutation of the CDK phosphory-
tion, and that CDK3 and CDC2 do not play direct roles lation site at Thr-490 (Figure 3D). Neither treatment is
in posttranscriptional regulation of RAG-2 expression. accompanied by a significant increase in the level of
The phenotypic effects of dn CDKs can be relieved, processed RAG-2 transcripts (data not shown). Thus,
directly or indirectly, by overexpression of particular the stimulation of RAG-2 accumulation by p27Kip1 and
cyclins (van den Heuvel and Harlow, 1993). Cyclin A, dn CDK2 is largely mediated by an increase in RAG-2
cyclin E, and D-type cyclins are all found in active CDK stability. The effects on RAG-2 half-life are specific;
complexes near the time when RAG-2 destruction be- p27Kip1 and dn CDK2 have little effect on the half-life of
gins; these were therefore tested for their ability to inter- bulk labeled protein in total cell lysates (data not shown).
fere with the effects of wt and dn CDK overexpression For example, the half-lives of three anonymous, ran-
on RAG-2 accumulation. domly selected proteins were not altered by more than
Overexpression of cyclin A reversed the hyperaccu- 1.5-fold upon transfection of p27Kip1 (data not shown).
mulation of RAG-2 induced by transfection of wt and We conclude that the stimulation of RAG-2 accumula-
tion by p27Kip1 or dn CDK2 is largely due to a profound,mutant CDK2 (Figure 2A, compare lanes 4 and 6 to 3
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Figure 3. Cyclin-Dependent Kinase Inhibitors p21Cip1, p27Kip1, and p57Kip2 Induce Accumulation of RAG-2 Protein
(A±C) Constant amounts of a RAG-2-expressing plasmid were cotransfected into 293 cells together with varying amounts of p21Cip1 (A), p27Kip1
(B), or p57Kip2 (C). At 48 hr after transfection, RAG-2 and p27Kip1 were assayed by immunoblotting as indicated. Lanes 1, vector alone; lanes
2, RAG-2; lanes 3±6 (A and C) or lanes 3±7 (B), RAG-2 and CKI, as indicated in micrograms.
(D) Prolongation of RAG-2 half-life by dn CDK2 and p27Kip1. A pulse-chase experiment was performed as described (Li et al., 1996). In brief,
293 cells were transfected with wt or Thr-490→Ala mutant RAG-2; dn CDK2 or p27Kip1 (10 mg plasmid) were cotransfected or omitted as
indicated in legend. At 48 hr after transfection, cells were pulse labeled for 15 min with [35S]methionine. Label was chased in medium containing
a 30,000-fold excess of unlabeled methionine and 10 mg/ml cyclohexamide. At various times, radiolabeled RAG-2 was immunoprecipitated
with antibody 435, fractionated by SDS PAGE, and quantitated by phosphorimaging. Data are normalized to the levels at time zero after pulse,
and this value (fraction RAG-2 remaining) is plotted logarithmically as a function of time. Individual curves are identified below.
specific prolongation of RAG-2 protein half-life, al- RAG-2 accumulation and V(D)J recombination were
assayed at 48 hr after transfection. As expected, p27Kip1though we cannot eliminate the possibility of other con-
and dn CDC2 greatly stimulated accumulation of RAG-2tributory factors.
(compare Figures 4A, lanes 3±7, and 4B, lanes 3±5, to
Figures 4A and 4B, lanes 2). Strikingly, an increase ofInduction of V(D)J Recombination by p27Kip1
about 10-fold in signal joint formation was observedThe ability of p27Kip1 to induce accumulation of RAG-2
upon overexpression of p27Kip1 at all levels of RAG-2prompted us to test its effect on the frequency of
transfection (Figure 4A, upper panel, lanes 4±7). No in-V(D)J recombination, as measured by an extrachromo-
crease was observed upon transfection with dn CDC2somal assay (see Experimental Procedures). Because
(Figure 4A, lane 3), despite the fact that the amountG1 is prolonged by p27Kip1 through its effect on cyclin
of RAG-2 expressed in the dn CDC2 transfectant wasA±associated kinase activity (Resnitzky et al., 1995), we
greater than in the p27Kip1 transfectant that received theused dn CDC2, which induced hyperaccumulation of
lowest amount of RAG-2 plasmid (Figure 4A, compare
RAG-2 nonspecifically (see Figure 1A), to determine the
lanes 3 and 4). A 40-fold relative increase in the fre-
effect of RAG-2 hyperaccumulation on V(D)J recombina- quency of coding joint formation was observed in
tion in the absence of G1 prolongation. RAG-1 and RAG-2 p27Kip1-transfected cells (Figure 4B, upper panel, lanes
were assayed in 293 cells for their ability to support 4 and 5). A more modest increase of about 5-fold was
formation of signal joints and coding joints on the sub- observed in the dn CDC2-transfected cells, although
strates pJH200 (Hesse et al., 1987) and pJH290 (Lieber RAG-2 was induced to a much greater level than in
et al., 1988), respectively, in the absence or presence the p27Kip1 transfectants (Figure 4B, lane 3). The greater
of overexpressed p27Kip1 or dn CDC2 (Figure 4). Fixed relative increases observed for pJH290 reflect its 4-fold
amounts of pJH200 (Figure 4A) or pJH290 (Figure 4B) lower basal recombination frequency (0.05%) in com-
and a RAG-1-expressing plasmid were transfected into parison to pJH200 (0.19%). No significant differences in
293 cells together with (1) a fixed amount of a p27Kip1- the yields of substrate plasmids were observed between
expressing plasmid and increasing amounts of a RAG- p27Kip1 and dn CDC2 transfectants (data not shown),
2-expressing plasmid (Figure 4A, lanes 4±7; Figure 4B, nor could the difference in recombination frequency be
lanes 4 and 5), (2) plasmids encoding dn CDC2 and explained by differential accumulation of RAG-1 (Fig-
RAG-2 (Figure 4A and B, lanes 3), or (3) a RAG-2-express- ure 4C).
ing plasmid alone (Figure 4A and B, lanes 2). Cells trans- The signal and coding junctions that were formed in
fected with pJH200 or pJH290 alone were assayed in the presence of p27Kip1 were examined to confirm that
they were genuine V(D)J recombination products. V(D)Jparallel as negative controls (Figures 4A and 4B, lanes 1).
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Figure 4. Stimulation of V(D)J Recombination by p27Kip1
(A) Signal joint formation. The substrate pJH200, pcRAG-1, and pcDNA1-p27Kip1 (lanes 4±7) or a plasmid encoding dn CDC2 (lane 3) were
cotransfected into 293 cells with differing amounts of pcRAG-2, as indicated. Control cells were transfected in parallel with pJH200, pcRAG-1,
and pcRAG-2 (lane 2) or with pJH200 alone (lane 1). DNA was equalized by addition of pcDNA1 vector. RAG-2 protein and V(D)J recombination
were assayed at 48 hr after transfection. Top panel, recombination frequencies, normalized to results obtained in the absence of p27Kip1 or
dn CDC2. Transfections were performed in triplicate; means and standard errors are indicated. Middle panel, RAG-2 was detected by
immunoblotting. Bottom panel, pJH200 and its signal joint product. RSSs are indicated by open and closed triangles and coding flanks by
open boxes. The intact ampicillin resistance marker (ªAmpº), interrupted chloramphenicol resistance marker (ªPrº and ªCATº) and transcriptional
terminators (stop) are indicated.
(B) Coding joint formation. Fixed amounts of the extrachromosomal V(D)J recombination substrate pJH290, pcRAG-1, and pcDNA1-p27Kip1
(lanes 4 and 5) or a plasmid encoding dn CDC2 (lane 3) were cotransfected into 293 cells with differing amounts of pcRAG-2, as indicated.
Control cells were transfected in parallel with pJH290, pcRAG-1, and pcRAG-2 (lane 2) or with pJH290 alone (lane 1). Top and middle panels,
relative recombination frequencies (means and standard errors of triplicate assays) and RAG-2 assays, displayed as in (A). Bottom panel,
pJH290 and its coding joint product, diagrammed as in (A).
(C) Comparison of RAG-1 protein expression in p27Kip1 and dn CDC2 transfectants. Expression of RAG-1 protein was assayed under the same
conditions as in (A), lanes 3 and 7. RAG-1 and RAG-2 were coexpressed with p27Kip1 or dn CDC2. Lysates were prepared 48 hr after transfection;
RAG-1 and RAG-2 were detected by immunoblotting as described in Experimental Procedures. Lane 1, RAG-1 (5 mg), RAG-2 (5 mg), and
p27Kip1 (10 mg); lane 2, RAG-1 (5 mg), RAG-2 (5 mg), and dn CDC2 (10 mg).
(D) Signal and coding junctions obtained from p27Kip1 transfectants are identical to normal V(D)J recombination products. Top, signal joints.
The unrearranged pJH200 RSSs are shown in the upper two lines. Heptamer and nonamer sequences are indicated by lowercase letters.
Signal junctions, shown in the third line, were identical (78/78). Bottom, coding joints. The coding-heptamer boundaries in the unrearranged
pJH290 substrate are shown in the top line. The heptamer is indicated by lowercase letters. Coding junction sequences are aligned below.
The number of occurrences of a particular sequence is given at right. P element insertions are noted by boldface type. Asterisk marks a C
residue at one junction not accounted for by P element insertion.
(E) Cell cycle analysis of p27Kip1 and dn CDC2 transfectants. Five micrograms of phGFP-S65T were cotransfected with pcDNA1 (left), p27Kip1
(middle), or dn CDC2 (right) into 293 cells. GFP-positive cells were isolated by FACS and analyzed for cell cycle distribution after staining
with propodium iodide. Horizontal axis, DNA content. Vertical axis, number of cells. The percentage of cells in G1, S, or G2/M was calculated
using the program ModFit LT (Verity).
recombination results in precise head-to-head joining p27Kip1 transfectants were also characteristic of V(D)J
recombination products (Lewis, 1994), in that they ex-of RSSs (Lewis, 1994). In a sample of 78 recombinant
junctional sequences from p27Kip1 transfectants, all con- hibited loss of variable numbers of base pairs from cod-
ing sequences and occasional P element insertions (Fig-tained precise signal joints, consistent with the interpre-
tation that they were produced by V(D)J recombination ure 4D).
The ability of p27Kip1 to stimulate V(D)J recombination
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comparison to 36.7% G1 in the absence of transfected
CKI and 50.7% G1 in the presence of transfected p27Kip1).
This suggests that G1 delay is an independent variable
controlling the frequency of V(D)J recombination in addi-
tion to accumulation of RAG-2 protein.
Enforced Expression of RAG-2 Throughout Cell
Cycle Is Associated with Increased Formation
of Aberrant Signal Joints in Transgenic Mice
The NHEJ repair pathway, which is responsible for com-
pletion of V(D)J recombination, appears to dominate in
repair of DSBs during G1 and early S phase (Maser et
al., 1997; Takata et al., 1998). We therefore speculated
that the failure of RAG-2 to accumulate outside of G1
may serve to restrict initiation of V(D)J recombination
to a period in the cell cycle when NHEJ is preferentially
active.
If this were correct, then enforced expression of RAG-2
throughout the cell cycle would support production of
DSBs at times when repair pathways other than NHEJ
dominate. The rare, NHEJ-independent signal joints that
are formed in Ku86-deficient mice can be distinguished
from normal products of V(D)J recombination by the
presence of coding sequence insertions between the
heptamers or the occurrence of deletions from one or
both signal ends (Bogue et al., 1997). Transgenic miceFigure 5. p57Kip2 Induces Accumulation of RAG-2 without Stimulat-
expressing the constitutive RAG-2 Thr-490→Ala mutanting V(D)J Recombination or Inducing G1 Delay
on a RAG-22/2 background (Li et al., 1996) were com-(A) The substrate pJH200 (10 mg), pcRAG-1 (5 mg), pcRAG-2 (5
pared to RAG-22/2 mice bearing the wt RAG-2 transgenemg), and pcDNA1-p57Kip2 (10 mg) were cotransfected into 293 cells.
Control cells were transfected in parallel with pJH200, pcRAG-1, (Li et al., 1996) and normal mice for evidence of NHEJ-
and pcRAG-2 (lane 2) or with pJH200 alone (lane 1). DNA was equal- independent formation of Vb14-Db1 signal joints. (Vb14
ized by addition of pcDNA1 vector. RAG-2 protein and V(D)J recom- rearrangement is inversional, and signal joints are there-
bination were assayed at 48 hr after transfection. Upper panel, re-
fore retained in genomic DNA.) Precise heptamer-to-combination frequencies, normalized to results obtained in the
heptamer fusions were found at most (70%±80%) sig-absence of p57Kip2 coexpression. Transfections were performed in
nal junctions from all three sets of mice (Figure 6A).triplicate; means and standard errors are indicated. Lower panel,
RAG-2 was detected by immunoblotting. The remaining junctions from nontransgenic and wt
(B) Cell cycle distribution of p57Kip2 cotransfectants was analyzed transgenic mice contained apparent N-nucleotide inser-
and displayed as described in Figure 4 and Experimental Proce- tions of between one and eight basepairs, as previously
dures. Five micrograms of phGFP-S65T was cotransfected with
observed (Bogue et al., 1997); similar sequences werepcDNA1 (left panel), p57Kip2 (middle panel), or p27Kip1 (right panel)
found at signal joints from mice expressing the constitu-into 293 cells.
tive RAG-2 Thr-490→Ala mutant. In addition, the mutant
transgenic mice yielded aberrant joints in which four or
more nucleotides identical to the 59 end of the Db1could not be explained solely by its effect on the average
level of RAG-2 protein; one or more additional activities, coding region were retained at a site adjacent to the
Db1 heptamer (Figure 6A). With respect to retention ofperhaps also cell cycle-dependent, appeared to be lim-
iting for V(D)J recombination. This is in agreement with D coding sequence at the recombinant junction, these
abnormal joints resemble those obtained from Ku86-the finding that the RAG-2 Thr-490→Ala mutant, which
accumulates to a higher average level per cell as a result deficient mice, consistent with their inefficient formation
by a NHEJ-independent mechanism.of its resistance to destruction outside of G1, does not
support an increased frequency of V(D)J recombination Thymocytes from RAG-2 Thr-490→Ala transgenic
mice accumulate signal breaks in the G0/G1 andrelative to wt RAG-2 (unpublished data). Candidates for
limiting activities other than RAG-2 might include one G2/M cell cycle phases (Li et al., 1996). The majority
of thymocytes undergoing recombination at the TCRbor more proteins that function in DSB repair. In experi-
ments performed in parallel (Figure 4E), transfection of locus are in the G0 or G1 cell cycle phases (Hoffman
et al., 1996). Most of the Vb14-Db1 recombinants wep27Kip1 into 293 cells was accompanied, as expected,
by an increase in the G1 fraction (48% G1) relative to observed were therefore likely to have been produced
during G0/G1. The yield of aberrant signal joints ob-cells transfected with dn CDC2 (37% G1) or cells that
received neither (38% G1). Although p57Kip2 induced hy- tained from RAG-2 Thr-490→Ala transgenic mice is low
in comparison to the yield of normal joints, consistentperaccumulation of RAG-2 protein in 293 cells, it did
not enhance V(D)J recombination frequency in the extra- with the relative paucity of cells in S or G2/M, during
which phases the effect of RAG-2 Thr-490→Ala is ex-chromosomal assay (Figure 5A). Measurement of cell
cycle distribution (Figure 5B) showed that p57Kip2 failed pected to be most prominent. Alternatively or in addi-
tion, the repair of RAG-induced DSBs by mechanismsto increase the G1 fraction significantly (39.6% G1, in
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Figure 6. Enforced RAG-2 Accumulation Outside of G1 Increases Formation of Aberrant Signal Joints In Vivo
(A) Vb14-Db1 signal junctions from splenic T cells of nontransgenic mice (upper panel), mice expressing the wt RAG-2 transgene on a RAG-22/2
background (middle panel), or mice expressing the RAG-2 Thr-490→Ala transgene on a RAG-22/2 background (lower panel). The recombination
signal sequences (RSS) of Vb14 and Db1 are indicated by lowercase letters; N-nucleotide insertions and Db1 coding insertions are in capital
letters. Insertions with four or more nucleotides of identity to Db1 coding sequence are marked by parentheses. Heptamer and nonamer
sequences are underlined. The number of occurrences of a particular sequence is given at right.
(B) Assay for aberrant Vb14-Db1 signal junctions retaining 8 bp or more of Db1 coding DNA. Arrows indicate the relative locations and
directions of each primer. Approximate distances are indicated by the scale at the top.
(C) Increased formation of aberrant Vb14-Db1 signal junctions from RAG-2 Thr-490→Ala transgenic mice. First round (Vb14.3/Db1.2) and
second round (Vb14.3/D-retention) PCR products are marked. The locations of DNA size markers are indicated at left. Lane 1, no DNA; lane
2, splenic T cell DNA from mice expressing the wt RAG-2 transgene on a RAG-22/2 background; lanes 3±8, undiluted and serially diluted
splenic T cell DNA from mice expressing the RAG-2 Thr-490→Ala transgene on a RAG-22/2 background.
(D) Nucleotide sequences of aberrant signal junctions from RAG-2 transgenic mice. Vb14.3/D-retention sequences from splenic T cells of
mice expressing the wt RAG-2 transgene on a RAG-22/2 background (upper panel), or mice expressing the RAG-2 Thr-490→Ala transgene
on a RAG-22/2 background (lower panel). RSSs of Vb14 and Db1 are indicated by lowercase letters; N-nucleotide insertions and Db1 coding
insertions are in capital letters. Insertions identical to the Db1 coding sequence are underlined. The sequences contributed by the D-retention
primer are in parentheses.
predominating outside of G0/G1 may be inherently inef- amplified (Figure 6B and Experimental Procedures). Ab-
errant signal joints retaining D coding nucleotides wereficient, as suggested by the low frequency of signal
joining observed in the absence of Ku86 (Bogue et al., at least ten times more abundant in pooled splenic DNA
from RAG-2 Thr-490→Ala transgenic mice than from wt1997). These arguments could explain why the overall
frequency of signal joint formation is similar in RAG-2 RAG-2 transgenic mice (Figure 6C). The identity of the
recombinant products detected by this assay was con-Thr-490→Ala and wild-type RAG-2 transgenic mice.
To determine whether abnormal signal junctions re- firmed by cloning and nucleotide sequencing (Figure
6D). The majority of clones (9/11 from wild-type RAG-2taining D coding sequence were preferentially formed
in mice expressing the RAG-2 Thr-490→Ala transgene, transgenic mice and 12/18 clones from RAG-2 Thr-
490→Ala transgenic mice) exhibited retention of D cod-we used a PCR assay in which signal joints retaining 8 bp
or more of Db1 coding sequence would be preferentially ing sequence at the signal junction, as evidenced by
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recombination despite stimulation of RAG-2 accumula-
tion is consistent with this model, as neither treatment
is accompanied by prolongation of G1, when NHEJ is
most active.
We have considered the formal possibility that the
increase in aberrant signal joints in the RAG-2 Thr-
490→Ala transgenic mice is due to a direct effect of this
mutation on the fidelity of the recombinase. Although
the available data do not eliminate this possibility, it
would appear unlikely because the RAG-2 core, which
lacks residues 387±527, produces signal joints that are
indistinguishable from normal, physiologic products.
Hybrid joints may be formed by nucleophilic attack
of a hairpin coding end by the free 39-hydroxyl group of
a signal end (Bogue et al, 1997). The aberrant junctions
we observe here seem unlikely to be explained by this
process. First, hybrid joint formation would require in-
correct pairing of the Db1 23-spacer RSS with the Vb14Figure 7. A Model for Regulation of V(D)J Recombination by Extra-
23-spacer RSS. This would violate the 12/23 spacer rulecellular Factors
and contradict the normal order of rearrangement at theFor explanation, see text.
TCRb locus, at which V-to-DJ recombination occurs only
after D-to-J recombination. Under this constraint the
Db1 23-RSS would not be available for rearrangementthe presence of additional D coding nucleotides beyond
to Vb14. Second, hybrid joints do not show deletionalthe 39 end of the D-retention primer (Figure 6D). The
modification of signal ends despite variable nucleotiderare occurrence of similar aberrant signal joints in normal
loss from coding ends. Most of the aberrant signal jointsmice (Carroll et al., 1993) may reflect carryover of signal
presented here, however, exhibit nucleotide loss fromend complexes from G0/G1 into S or G2/M.
the Vb14 signal end.One difference between the aberrant signal joints ob-
served in RAG-2 Thr-490→Ala transgenic mice and
Implications for Regulation of V(D)J RecombinationKu86-deficient mice is the relative lack of extensive exo-
by Extracellular Signalsnucleolytic modification in the former. Because RAG-2
The convergence of multiple signaling pathways onThr-490→Ala has a 20-fold longer half-life than wt RAG-2
cyclin A/CDK2 has interesting implications for the con-(Lin and Desiderio, 1993), signal end complexes con-
trol of V(D)J recombination (Figure 7). IL-7, which in-taining RAG-1 and RAG-2 Thr-490→Ala may be more
duces CDK2 activity (Itoh et al., 1996) and stimulatesstable than those containing RAG-1 and wt RAG-2. If
G1/S progression, inhibits V(D)J recombination in lym-so, signal ends bound to RAG-1 and RAG-2 Thr-
phoid progenitors (Yasunaga et al., 1995). Conversely,490→Ala may be relatively protected from the extensive
free p27Kip1 is increased by TGFb (Reynisdottir et al.,exonucleolytic modification that was oberved in Ku862/2
1995), which retards cell cycle progression of CD4-CD8lomice expressing wt RAG-2 (Bogue et al., 1997).
precursor cells (Takahama et al., 1994); assembly of
heavy and light chain genes occurs during periods of
relatively slow cell division or cytostasis (Lin and Desi-Coordination of V(D)J Recombination
derio, 1995), consistent with the idea that protraction ofand DNA Repair
G1 predisposes toward V(D)J recombination. Bleomy-The repair of DNA gaps by homologous recombination
cin, a DNA damaging agent, induces G2 arrest and hy-can produce repair junctions similar to the aberrant sig-
peraccumulation of RAG-2 in stably transfected NIH 3T3nal joints observed in RAG-2 Thr-490→Ala transgenic
cells; consistent with results presented above, this ismice by a mechanism involving capture of adjacent tem-
unaccompanied by an increase in the frequency of V(D)Jplate sequences by one end of the DNA break and modi-
recombination (unpublished data). The inability of bleo-fication of the other DNA end (Belmaaza et al., 1994).
mycin to increase the frequency of V(D)J recombina-Human Rad52 protein (hRad52) possesses a DNA end
tion in the transfection assay may reflect inefficient join-binding activity similar to that of Ku. It has been sug-
ing of signal ends produced during G2 delay. Undergested that hRad52 and Ku are mutually exclusive for
such conditions, unless apoptosis results, repair ofDNA end binding, and that this exclusive occupancy
RAG-induced DSBs by a mechanism other than thatof DNA ends may define whether repair proceeds by
used in normal V(D)J recombination may predisposehomologous recombination or NHEJ (Van Dyck et al.,
toward genomic instability and possibly malignancy.1999). Taken together, these observations support a
model in which G1-specific accumulation of RAG-2 co-
Experimental Proceduresordinates RSS cleavage with NHEJ activity. Under this
interpretation the NHEJ repair pathway, which is re-
Cell Culture, Plasmids, and Transfectionstricted to the G1 and early S phases (Takata et al.,
The human embryonic kidney cell line 293 was propagated in DMEM
1998), would be rate limiting for V(D)J recombination supplemented with 10% fetal bovine serum. Transient transfection
under conditions in which RAG-2 protein is abundant. was performed by the calcium phosphate method. The following
plasmids have been described previously: pCMV-cdk2wt-HA,The inability of dn CDC2 and p57Kip2 to enhance V(D)J
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pCMV-cdk2dn-HA, pCMV-cdk3wt-HA, pCMV-cdk3dn-HA, pCMV- PCR Assay for Retention of D Coding Sequence
at Signal Jointscdc2wt-HA, pCMV-cdc2dn-HA (van den Heuvel and Harlow, 1993);
Rc-cycA, Rc-cycE, Rc-cycD1 (Hinds et al., 1992); pcRAG-1, pcRAG-2 To detect aberrant Vb14-Db1 signal juctions retaining 8 bp or more
of Db1 coding sequence, two rounds of PCR were performed. Reac-(Lin and Desiderio, 1993); pJH200 (Hesse et al., 1987); pJH290
(Lieber et al., 1988); and pCMV-Cip1 (Harper et al., 1993). The plas- tions (100 ml) contained 1 mg pooled, genomic splenic T cell DNA,
10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl2, 50 mM KCl, 300 nM Vb14.3mid pcDNA1-p27Kip1 was constructed by ligating the p27Kip1-encod-
ing BamH1±Nde1 fragment of pCRII-mp27Kip1 (Matsuoka et al., 1995) upstream primer (59-ATGATGGAGATACTCCCAGA-39), 300 nM
Db1.2 downstream primer (59-TGTGGTTACATCACGTCATTT-39),into pcDNA1 (Invitrogen). pcDNA1-p57Kip2 was constructed by ligat-
ing the p57Kip2-encoding HindIII±Xbal fragment of CMV-mp57Kip2 and 200 mM dNTP. Samples were incubated for 4 min at 948C
followed by 25 cycles of 1 min at 948C, 1 min at 568C, and 1.5 min(Matsuoka et al., 1995) into pcDNA1.
at 728C with 10 min at 728C in the final extension step. The first-round
PCR product (2 ml) was reamplified. Second-round amplificationImmunoblot Assays
was performed under the same conditions as the first amplification,Transiently transfected cells were harvested 48 hr after transfection,
except that 200 nM Vb14.3 upstream primer and 200 nM D-retentionwashed once in PBS; lysed in 60 mM Tris-C1 (pH 7.6), 1% SDS;
primer (59-GTAACATTGTGGGGACAAG-39) were used. Samplesand boiled for 5 min. Protein concentration was determined by BCA
were incubated for 4 min at 948C followed by 25 cycles of 30 s atassay (Pierce), and equal amounts of lysate (100 mg per sample)
958C, 30 s at 638C, and 1 min at 728C with 10 min at 728C in the finalwere analyzed by SDS-PAGE. Protein was transferred to nitrocellu-
extension step. The high frequency of CC N-nucleotide insertions atlose. RAG-2 and RAG-1 were detected by immunoblotting with affin-
the signal junctions in all mice (4/77 in wt RAG-2 transgenic mice;ity-purified rabbit antibodies 432 and 307, respectively (Lin and
6/80 in RAG-2 Thr-490→Ala transgenic mice) produced a highDesiderio, 1993), followed by development with horseradish peroxi-
background signal in pilot assays. To decrease this background,dase (HRP)-coupled donkey anti-rabbit IgG (NA 934; Amersham
an A nucleotide was substituted for G at the second 39 position ofSciences). CDK2-HA, CDK3-HA, and CDC2-HA were detected with
D-retention primer. This was expected to weaken hydrogen bondinga mouse monoclonal anti-HA antibody (12CA5; Boehringer Mann-
to template DNA of CC insertion signal junctions (Kwok et al., 1990).heim) and HRP-coupled sheep anti-mouse IgG (NA 9310; Amersham
PCR products were analyzed on a 1.2% TAE agarose gel and trans-Life Science). p27Kip1 was detected with a goat polyclonal anti-p27Kip1
ferred to Hybond-N nylon membrane (Amersham Life Science). Ra-IgG antibody (N-20; Santa Cruz), followed by incubation with HRP-
diolabled Vb14 SIGNAL oligonucleotide was hybridized to the mem-coupled donkey anti-goat IgG (705-035-147; Jackson ImmunoRe-
brane at 428C overnight. The membrane was washed twice withsearch). Immobilized HRP was visualized by an enhanced chemilu-
2XSSC, 0.1% SDS at room temperature and analyzed using a Phos-minescence assay (Amersham).
phorImager and ImageQuant (Molecular Dynamics). To clone the
Vb14.3/D-retention joints, DNA migrating near 500 bp on agarose
Extrachromosomal Assays for V(D)J Recombination gels was isolated and cloned into the pCR2.1 vector (Invitrogen).
Recipient 293 cells were transfected by the calcium phosphate Insert DNA was sequenced using the oligonucleotide Vb14 SIGNAL
method with pJH200 or pJH290 (10 mg), pcRAG-1 (5 mg), pcDNA1- as a primer.
p27Kip1 or pCMV-cdc2dn-HA (10 mg), and varying amounts of
pcRAG-2 ranging from 0.5 mg to 5 mg. The vector pcDNA1 was
Received September 20, 1999; revised November 3, 1999.
added to maintain the total amount of DNA constant. Cells were
harvested at 48 hr after transfection and V(D)J recombination was
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